1-20 of 30
Jeffrey Ross
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P5-13-02: Serially biopsied BRCA1/2 mutant breast tumors frequently acquire alterations in BRCA1, BRCA2, and CREBBP

Ethan Sokol, Smruthy Sivakumar, Brennan Decker, Jeffrey Ross, Priti Hegde
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P5-13-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P5-13-02
Published: 15 February 2022
View article
Journal Articles

Abstract P2-08-03: PD-L1 protein expression in relation to Recurrence Score values in early stage ER+HER2- breast cancer

Kim RM Blenman, Malini Harigopal, Richard Huang, Emily Reisenbichler, Tao Qing, Eiman Ibrahim, Kamaljeet Singh, Shakti Ramkissoon, Roberts Mustimbo, Jeffrey Ross, Lajos Pusztai
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P2-08-03.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P2-08-03
Published: 15 February 2022
View article
Journal Articles

Abstract P3-09-10: NTRK1/2/3 fusions are observed in both secretory and non-secretory breast cancers

Ethan Sokol, Sophia Maund, Jeffrey Ross, Timothy Wilson
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P3-09-10.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P3-09-10
Published: 15 February 2022
View article
Journal Articles

Abstract PD8-01: Comprehensive genomic profiling (CGP) of metastatic invasive lobular carcinomas reveals heterogeneity in immune biomarkers and resistance alterations across biopsy sites

Ethan Sokol, Dexter X Jin, Jeffrey Ross, Garrett M Frampton, Steffi Oesterreich
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PD8-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PD8-01
Published: 15 February 2021
View article
Journal Articles

Abstract PS5-08: Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers

Mariya Rozenblit, Richard Huang, Natalie Danziger, Brian Alexander, Shakti Ramkissoon, Kim Blenman, Jeffrey Ross, David Rimm, Lajos Pusztai
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS5-08.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS5-08
Published: 15 February 2021
View article
Journal Articles

Abstract 1017: RICTOR/mTOR signaling regulates novel immune checkpoints in non-small cell lung cancer (NSCLC)

Mariam Alexander, Ni Fan, Xiaoxin Ren, Jeffrey Ross, Hao Wang, Feng Wang, Balazs Halmos, Roman Perez-Soler, Xingxing Zang, Haiying Cheng
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 1017.
DOI: https://doi.org/10.1158/1538-7445.AM2020-1017
Published: 15 August 2020
View article
Journal Articles

Abstract 4894: Incidence of high tumor mutation burden (TMB) and PD-L1 positivity in breast cancers and potential response to immune checkpoint inhibitors (ICPIs)

Ethan Sokol, Lee Albacker, Aixa Soyano, Ricardo Parrondo, Brenda Ernst, Emmanuel Gabriel, Garrett Frampton, Jeffrey Ross, Siraj Ali, Jon Chung, Saranya Chumsri
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4894.
DOI: https://doi.org/10.1158/1538-7445.AM2019-4894
Published: 01 July 2019
View article
Journal Articles

Abstract 1607: An ERBB2 follow-on companion diagnostic for clinical care of patients with breast cancer

Wai-ki Yip, Joel Skoletsky, Pei Ma, Jun Luo, Coren Milbury, Christine Burns, John Truesdell, Julia Elvin, Geoff Otto, Doron Lipson, Jeffrey Ross, Vincent Miller, Philip Stephens, Michael Doherty, Christine Vietz, James X. Sun, Yali Li
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 1607.
DOI: https://doi.org/10.1158/1538-7445.AM2018-1607
Published: 01 July 2018
View article
Journal Articles

Abstract 320: Frequency and patient characteristics of homologous recombination deficiency in metastatic cutaneous melanoma

Kevin B. Kim, Sherri Z. Millis, Jeffrey Ross, Laurie M. Gay, Elham Vosoughi, John Moretto, Stanley P. Leong, Mark I. Singer, Brian M. Parrett, David R. Minor, Mohammed Kashani-Sabet
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 320.
DOI: https://doi.org/10.1158/1538-7445.AM2018-320
Published: 01 July 2018
View article
Journal Articles

Abstract 2582: A novel PI3K/Akt-pathway activation biomarker using comprehensive genomic profiling (CGP) for clinical trial assay

Yuting He, Matthew Wongchenko, Joel Skoletsky, Christine Burns, Yali Li, Paula Maness, Doris Kim, Doron Lipson, Philip Stephens, Vincent Miller, Jeffrey Ross, Steven Gendreau, James Sun
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2582.
DOI: https://doi.org/10.1158/1538-7445.AM2018-2582
Published: 01 July 2018
View article
Journal Articles

Abstract 4757: A clinically validated comprehensive companion diagnostic platform for care of patients with advanced cancer

James X. Sun, Yali Li, Coren Milbury, Joel Skoletsky, Christine Burns, Wai-ki Yip, Jun Luo, Ninad Dewal, Adrienne Johnson, Kyle Gowen, Jing Tong, Yuting He, Jie He, Pei Ma, Jared White, Steve Roels, John Truesdell, Eric Peters, Houston Gilbert, Charlie Wu, Erica Schleifman, Johannes Noe, Carl Barrett, Kenneth Thress, Suzanne Jenkins, Julia Elvin, Geoff Otto, Doron Lipson, Jeffrey Ross, Vincent Miller, Philip Stephens, Michael Doherty, Christine Vietz
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 4757.
DOI: https://doi.org/10.1158/1538-7445.AM2018-4757
Published: 01 July 2018
View article
Journal Articles

Abstract 4544: A validated diagnostic assay for identifying ovarian cancer patients with deleterious BRCA mutations and high genomic loss of heterozygosity (LOH)

James X. Sun, Kevin Lin, Yali Li, Kyle Gowen, Yuting He, Coren Milbury, Christine Burns, Jun Luo, Steve Roels, Murtaza Mehdi, John Truesdell, Pei Ma, Lakshman Ramamurthy, Christine Vietz, Jeri Beltman, Thomas Harding, Doron Lipson, Jeffrey Ross, Vincent Miller, Philip Stephens, Michael Doherty, Julia Elvin
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 4544.
DOI: https://doi.org/10.1158/1538-7445.AM2018-4544
Published: 01 July 2018
View article
Journal Articles

Abstract CT053: High rates of personalized molecular matching are achievable in a precision oncology navigation trial: the I-PREDICT study

Jason K. Sicklick, Brian Leyland-Jones, Shumei Kato, Casey Williams, Pradip De, Gregory Heestand, Steven Plaxe, Benjamin Solomon, Vincent Miller, Adam Benson, Jennifer Webster, Jeffrey Ross, Michael Scur, Robert Porter, Shelby Jepperson, Paul Fanta, Razelle Kurzrock
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): CT053.
DOI: https://doi.org/10.1158/1538-7445.AM2017-CT053
Published: 01 July 2017
View article
Journal Articles

Abstract 2367: Identification of ALK alternative transcription initiation in BRAF-negative metastatic melanoma patients

Shan Zhong, Christine Lovly, Christine Malboeuf, Kristina Brennan, Douglas Johnson, Kelsie Riemenschneider, Catherine Meador, Emily White, Geoff A. Otto, Doron Lipson, Philip Stephens, Vincent Miller, Jeffrey Ross, Jie He
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 2367.
DOI: https://doi.org/10.1158/1538-7445.AM2017-2367
Published: 01 July 2017
View article
Journal Articles

Abstract LB-178: Genomic profiling of 1239 diverse pediatric cancers identifies novel discoveries across tumors

Juliann Chmielecki, Mark Bailey, Jie He, Julia Elvin, Jo-Anne Vergilio, Shakti Ramkissoon, James Suh, Garrett M. Frampton, Siraj Ali, Jeffrey Ross, Vincent A. Miller, Philip J. Stephens, Doron Lipson
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): LB-178.
DOI: https://doi.org/10.1158/1538-7445.AM2016-LB-178
Published: 15 July 2016
View article
Journal Articles

Abstract LB-328: Subtypes of urothelial carcinoma of the urinary bladder defined by genomic alteration combinations predict clinical characteristics

Alyna Khan, Alex Fichtenholtz, Jeffrey Ross, Garrett Frampton, Eric Neumann, Siraj M. Ali, Phil J. Stephens
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): LB-328.
DOI: https://doi.org/10.1158/1538-7445.AM2016-LB-328
Published: 15 July 2016
View article
Journal Articles

Abstract 967: Massively parallel sequencing of clinical FFPE cancer specimens enables comprehensive genomic assessment of patient eligibility for targeted therapy

Roman Yelensky, Mirna Jarosz, Sean Downing, Kai Wang, Doron Lipson, Frank Juhn, Kristina Brennan, Garrett Frampton, Alex Parker, John Curran, Philip Stephens, Jeffrey Ross, Maureen Cronin
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 967.
DOI: https://doi.org/10.1158/1538-7445.AM2012-967
Published: 15 April 2012
View article
Journal Articles

Abstract LB-88: Identification of recurrent oncogenic KIF5B-RET rearrangements in non-small cell lung cancer

Marzia Capelletti, Doron Lipson, Geoff Otto, Roman Yelensky, Dalia Ercan, Jhingook Kim Kim, Hidefumi Sasaki, Hyeong Ryul Kim, Seung-il Park, Jeffrey Ross, Philip J. Stephens, Maureen T. Cronin, Pasi A. Jänne
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): LB-88.
DOI: https://doi.org/10.1158/1538-7445.AM2012-LB-88
Published: 15 April 2012
View article
Journal Articles

Abstract 3114: MLL2 overexpression and incomplete proteolytic processing in human cell lines from invasive breast and colon cancers

Thanemozhi G. Natarajan, Bhaskar V. Kallakury, Christine Sheehan, Margaret B. Bartlett, Natarajan Ganesan, Anju Preet, Jeffrey Ross, Kevin T. FitzGerald
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3114.
DOI: https://doi.org/10.1158/1538-7445.AM10-3114
Published: 15 April 2010
View article
Journal Articles

Abstract #4116: Mutation spectra induced by conazole fungicides in lacI transgenic C57BL/6 mouse liver

Jeffrey Ross, Sharon Leavitt
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 4116.
Published: 01 May 2009
View article